Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Characterization of the interface of the bone marrow stromal cell antigen 2-Vpu protein complex via computational chemistry.

Zhou J, Zhang Z, Mi Z, Wang X, Zhang Q, Li X, Liang C, Cen S.

Biochemistry. 2012 Feb 14;51(6):1288-96. doi: 10.1021/bi2015986. Epub 2012 Jan 30.

PMID:
22264038
2.

Identification of novel key amino acids at the interface of the transmembrane domains of human BST-2 and HIV-1 Vpu.

Pang X, Hu S, Li J, Xu F, Mei S, Zhou J, Cen S, Jin Q, Guo F.

Retrovirology. 2013 Aug 6;10:84. doi: 10.1186/1742-4690-10-84.

3.

The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.

Rong L, Zhang J, Lu J, Pan Q, Lorgeoux RP, Aloysius C, Guo F, Liu SL, Wainberg MA, Liang C.

J Virol. 2009 Aug;83(15):7536-46. doi: 10.1128/JVI.00620-09. Epub 2009 May 27.

4.

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.

Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, Sata T, Tokunaga K.

J Biol Chem. 2009 Dec 11;284(50):35060-72. doi: 10.1074/jbc.M109.058305. Epub 2009 Oct 16.

5.

Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.

Yoshida T, Koyanagi Y, Strebel K.

J Virol. 2013 Dec;87(24):13825-36. doi: 10.1128/JVI.02567-13. Epub 2013 Oct 9.

6.

High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2.

Zhang Q, Liu Z, Mi Z, Li X, Jia P, Zhou J, Yin X, You X, Yu L, Guo F, Ma J, Liang C, Cen S.

Antiviral Res. 2011 Sep;91(3):321-9. doi: 10.1016/j.antiviral.2011.07.007. Epub 2011 Jul 14.

PMID:
21777622
7.

Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.

Lv M, Wang J, Wang X, Zuo T, Zhu Y, Kong W, Yu X.

PLoS One. 2011;6(6):e20890. doi: 10.1371/journal.pone.0020890. Epub 2011 Jun 2.

8.

Sites of action of HIV-1 Vpu in BST-2/tetherin downregulation.

Arias JF, Iwabu Y, Tokunaga K.

Curr HIV Res. 2012 Jun;10(4):283-91. Review.

PMID:
22524176
9.

HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions.

Skasko M, Wang Y, Tian Y, Tokarev A, Munguia J, Ruiz A, Stephens EB, Opella SJ, Guatelli J.

J Biol Chem. 2012 Jan 2;287(1):58-67. doi: 10.1074/jbc.M111.296772. Epub 2011 Nov 9.

10.

HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.

Dubé M, Paquay C, Roy BB, Bego MG, Mercier J, Cohen EA.

Traffic. 2011 Dec;12(12):1714-29. doi: 10.1111/j.1600-0854.2011.01277.x. Epub 2011 Oct 3.

11.

HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.

Fritz JV, Tibroni N, Keppler OT, Fackler OT.

Virology. 2012 Mar 1;424(1):33-44. doi: 10.1016/j.virol.2011.12.008. Epub 2012 Jan 4.

12.

Transmembrane interactions of HIV-1 Vpu and tetherin.

Guo F, Liang C.

Curr HIV Res. 2012 Jun;10(4):292-7. Review.

PMID:
22524177
13.

Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Vigan R, Neil SJ.

J Virol. 2010 Dec;84(24):12958-70. doi: 10.1128/JVI.01699-10. Epub 2010 Oct 6.

14.

Purification of eukaryotic tetherin/Vpu proteins and detection of their interaction by ELISA.

Lv M, Zhu Y, Wang J, Zhang H, Wang X, Zuo T, Liu D, Zhang J, Wu J, Kong W, Yu X.

Protein Expr Purif. 2013 Oct;91(2):112-8. doi: 10.1016/j.pep.2013.07.015. Epub 2013 Aug 3.

PMID:
23916489
15.

[Establishment of a high-throughput screening assay for interaction inhibitor between BST-2 and Vpu].

Pang XJ, Hu SQ, Zhang Y, Cen S, Jin Q, Guo F.

Bing Du Xue Bao. 2012 Nov;28(6):633-8. Chinese.

PMID:
23367562
16.

A novel peptide to disrupt the interaction of BST-2 and Vpu.

Mi Z, Wang X, He Y, Li X, Ding J, Liu H, Zhou J, Cen S.

Biopolymers. 2014 May;102(3):280-7. doi: 10.1002/bip.22488.

PMID:
24676648
17.

Human immunodeficiency virus-1 BF intersubtype recombinant viral protein U second α helix plays an important role in viral release and BST-2 degradation.

De Candia C, Espada C, Duette G, Salomón H, Carobene M.

J Gen Virol. 2013 Apr;94(Pt 4):758-66. doi: 10.1099/vir.0.047746-0. Epub 2012 Dec 5.

PMID:
23223624
18.

Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.

Lopez LA, Yang SJ, Hauser H, Exline CM, Haworth KG, Oldenburg J, Cannon PM.

J Virol. 2010 Jul;84(14):7243-55. doi: 10.1128/JVI.02636-09. Epub 2010 May 5.

19.

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC.

PLoS Pathog. 2009 May;5(5):e1000450. doi: 10.1371/journal.ppat.1000450. Epub 2009 May 29.

20.

Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility.

Kobayashi T, Ode H, Yoshida T, Sato K, Gee P, Yamamoto SP, Ebina H, Strebel K, Sato H, Koyanagi Y.

J Virol. 2011 Jan;85(2):932-45. doi: 10.1128/JVI.01668-10. Epub 2010 Nov 10.

Supplemental Content

Support Center